# Science Corp Raises $230 Million to Bring Vision-Restoring Brain Implant to Market in 2026

*2026-03-06 20:04 UTC · Science · 1 min read*

> Science Corp raises $230M to commercialize PRIMA, a tiny retinal implant that restored vision in 80% of trial patients, with EU launch expected mid-2026.

Science Corporation closed a $230 million Series C round led by Lightspeed, Khosla Ventures, and Y Combinator, bringing total funding to $490 million. The startup's flagship product PRIMA is a 2-millimeter retinal implant with 378 pixel-electrodes that works with specialized infrared glasses to restore functional vision in patients with late-stage macular degeneration — the leading cause of blindness.

In clinical trials across Europe and the US involving 47 patients, 80% demonstrated meaningful improvement in visual acuity and were able to read letters, numbers, and words. Science Corp has submitted a CE mark application and expects EU approval in mid-2026, with an FDA application also in progress.

The company, founded by former Neuralink co-founder Max Hodak, operates its own fabrication facility in North Carolina and plans to use the new capital to scale manufacturing. Beyond PRIMA, Science Corp is developing Biohybrid, a higher-bandwidth brain-computer interface using electrodes and microLEDs.

## Sources

- [techcrunch.com](https://techcrunch.com/2026/03/05/science-corp-closes-230m-round-as-it-pushes-to-get-its-brain-implant-to-patients/)
- [siliconangle.com](https://siliconangle.com/2026/03/05/brain-computer-interface-startup-science-raises-230m/)

---
TechTools News · https://techtools.cz/tools/news/article/614-science-corp-raises-230-million-to-bring-vision-restoring-brain-implant-to
Česká verze: https://techtools.cz/tools/news/clanek/622-science-corp-ziskala-230-milionu-dolaru-na-uvedeni-mozkoveho-implantatu-pro
